New York State Common Retirement Fund Sells 4,601 Shares of Cardinal Health, Inc. $CAH

New York State Common Retirement Fund decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 1.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 327,147 shares of the company’s stock after selling 4,601 shares during the quarter. New York State Common Retirement Fund owned 0.14% of Cardinal Health worth $51,349,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in Cardinal Health in the second quarter worth approximately $584,420,000. Acadian Asset Management LLC increased its stake in shares of Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares in the last quarter. Prudential Financial Inc. raised its holdings in Cardinal Health by 476.8% in the 2nd quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock worth $148,402,000 after purchasing an additional 730,209 shares during the period. Voya Investment Management LLC lifted its position in Cardinal Health by 298.3% during the third quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after purchasing an additional 615,398 shares in the last quarter. Finally, AustralianSuper Pty Ltd lifted its position in Cardinal Health by 237.6% during the third quarter. AustralianSuper Pty Ltd now owns 680,173 shares of the company’s stock valued at $106,760,000 after purchasing an additional 478,689 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal hit an all-time high, reinforcing upside momentum and drawing more attention from momentum and trend-following buyers. Cardinal Health stock hits all-time high at $215.54
• Positive Sentiment: Morgan Stanley upgraded competitor Cencora, calling a “golden era” for drug distributors — a sector-level endorsement that likely lifts sentiment for Cardinal as a leading distributor. Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors
• Positive Sentiment: Multiple brokers and analysts are highlighting CAH as a top pick for Q4/early 2026, citing solid earnings trends and cooled inflation — this increases the likelihood of continued analyst revisions and inflows. 5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
• Positive Sentiment: Zacks expects CAH to report growing earnings next week and notes the company has the characteristics of a likely earnings beat — a near-term catalyst that can push the stock higher if results confirm expectations. Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
• Positive Sentiment: High-profile bullish commentary (e.g., Jim Cramer saying he can see CAH reaching $300) can attract retail flows and increase trading momentum. Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”
• Positive Sentiment: IBD highlights raised 2026 guidance and strong momentum, reinforcing the narrative that growth and execution are improving — supports higher valuations. IBD Stock Of The Day: Why Cardinal Health’s Momentum Is ‘Special’ — And Not Over Yet
• Positive Sentiment: Short interest fell ~15.9% in January, lowering potential downside pressure from short-covering dynamics and removing a near-term bearish crowd — fewer shorts can mean steadier rallies. (data summary)
• Neutral Sentiment: Zacks published a valuation-focused piece asking whether CAH is undervalued — useful for longer-term investors but less of an immediate price catalyst. Is Cardinal Health (CAH) Stock Undervalued Right Now?
• Neutral Sentiment: Routine earnings calendar note: Cardinal is expected to announce quarterly results Thursday — the report itself is the key near-term event that could change the stock’s direction. Cardinal Health (CAH) Expected to Announce Quarterly Earnings on Thursday

Wall Street Analyst Weigh In

CAH has been the subject of a number of analyst reports. Leerink Partners set a $240.00 price target on Cardinal Health in a research report on Tuesday, January 13th. UBS Group boosted their price objective on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Evercore ISI raised their target price on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Morgan Stanley upped their price target on shares of Cardinal Health from $224.00 to $245.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research note on Tuesday, November 18th. Fourteen research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $224.73.

Cardinal Health Price Performance

Cardinal Health stock opened at $211.02 on Friday. The firm’s 50 day moving average price is $206.13 and its 200-day moving average price is $177.53. Cardinal Health, Inc. has a 1 year low of $120.72 and a 1 year high of $216.51. The stock has a market cap of $50.14 billion, a P/E ratio of 31.83, a PEG ratio of 1.43 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. During the same period last year, the company posted $1.88 earnings per share. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were given a dividend of $0.5107 per share. The ex-dividend date was Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.